ESMO FAMILY SITES
Oncology News
10.03.10 Natural history and management of everolimus-induced oral ulcers
Everolimus-induced oral ulcers are very frequent and sometimes harmful complication
09.03.10 Effect of short-term endocrine therapy prior to and during radiation therapy on overall survival in patients with T1b-T2b adenocarcinoma of the prostate and PSA equal to or less than 20
Initial results of RTOG 94-08 study
08.03.10 Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel
Final results of a multinational phase III TROPIC trial
04.03.10 Actively targeting mTOR
Selective inhibitors of TORC1 and TORC2 might be superior to those that also inhibit PI3K and to rapamycin, and might be particularly effective when used with regimens that include dasatinib for treating Ph+ B-ALL
03.03.10 Kinase inhibitors: A winning combination against BCR–ABL
A selective allosteric inhibitor of BCR–ABL, GNF-5, cooperates with ATP competitive inhibitors to inhibit both wild-type and mutant forms of the kinase
BACK TO TOP
PRINT THIS PAGE